HA
Chief Technology Officer
Get the full picture
Sign in to uncover key details.
Pharmos
Manufacturing · Nevada, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
3609 Hammerkop Dr, North Las Vegas, Neva...Phone Number
(415) 841-3570Website
www.pharmoscorp.comRevenue
<$5 MillionStock Symbol
6875.TWOIndustry
About Pharmos
Pharmos Corporation is a biopharmaceutical company focused on discovering and developing innovative therapeutics for nervous system diseases, particularly targeting conditions like irritable bowel syndrome (IBS) and gout. The company is advancing Dextofisopam for IBS and Levotofisopam for gout, both of which have received FDA clearance for clinical trials. Pharmos seeks pharmaceutical partners to support the further development of its products due to limited financial resources. Additionally, the company has developed cannabinoid compounds for neuropathic pain, which are available for licensing or sale.Explore more
Pharmos Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Pharmos
Compare insights from companies similar to Pharmos, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Pharmos
<$5M
1-10
Public
-
1982
JM
James MeerSenior Vice President Chief Financial Officer Secretary Treasurer
Pharmos Tech Stack
A closer look at the technologies used by Pharmos
Top Manufacturing Companies
Frequently Asked Questions Regarding Pharmos
Sign Up For FreeTo access detailed company insights
Pharmos Corporation is a biopharmaceutical company focused on discovering and developing innovative therapeutics for nervous system diseases, particularly targeting conditions like irritable bowel syndrome (IBS) and gout. The company is advancing Dextofisopam for IBS and Levotofisopam for gout, both of which have received FDA clearance for clinical... Read More
